H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
about
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues.International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.Self-Assembled Nanostructures Regulate HS Release from Constitutionally Isomeric Peptides
P2860
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
@en
type
label
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
@en
prefLabel
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
@en
P2093
P50
P1476
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
@en
P2093
Alberto Gasco
Chiara Riganti
Daniela Cortese
Dario Ghigo
Elena Gazzano
Ilaria Buondonno
Konstantin Chegaev
Marilù Fanelli
Roberta Fruttero
P304
P356
10.1021/ACS.JMEDCHEM.6B00184
P407
P577
2016-04-27T00:00:00Z